CN103705733B - 一种治疗心律不齐的中药胶囊及其制备方法 - Google Patents
一种治疗心律不齐的中药胶囊及其制备方法 Download PDFInfo
- Publication number
- CN103705733B CN103705733B CN201410021576.6A CN201410021576A CN103705733B CN 103705733 B CN103705733 B CN 103705733B CN 201410021576 A CN201410021576 A CN 201410021576A CN 103705733 B CN103705733 B CN 103705733B
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- fructus
- filtrate
- gained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 47
- 238000002360 preparation method Methods 0.000 title claims description 26
- 239000003814 drug Substances 0.000 claims abstract description 43
- 241000218236 Cannabis Species 0.000 claims abstract description 19
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 16
- 239000000706 filtrate Substances 0.000 claims description 36
- 239000007779 soft material Substances 0.000 claims description 15
- 238000001035 drying Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 238000004321 preservation Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 20
- 206010003119 arrhythmia Diseases 0.000 abstract description 12
- 230000006793 arrhythmia Effects 0.000 abstract description 12
- 239000000463 material Substances 0.000 abstract description 4
- 239000012567 medical material Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 16
- 208000024891 symptom Diseases 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 13
- 210000003734 kidney Anatomy 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 10
- 208000002173 dizziness Diseases 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 206010033557 Palpitations Diseases 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 210000000582 semen Anatomy 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 230000002269 spontaneous effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 230000035900 sweating Effects 0.000 description 5
- 208000019255 Menstrual disease Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 208000013116 chronic cough Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 206010025482 malaise Diseases 0.000 description 4
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 238000013475 authorization Methods 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 230000000302 ischemic effect Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000033764 rhythmic process Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000208011 Digitalis Species 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 235000021152 breakfast Nutrition 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229960005181 morphine Drugs 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 210000002105 tongue Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 206010054196 Affect lability Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 239000005552 B01AC04 - Clopidogrel Substances 0.000 description 1
- XPCFTKFZXHTYIP-PMACEKPBSA-N Benazepril Chemical compound C([C@@H](C(=O)OCC)N[C@@H]1C(N(CC(O)=O)C2=CC=CC=C2CC1)=O)CC1=CC=CC=C1 XPCFTKFZXHTYIP-PMACEKPBSA-N 0.000 description 1
- 239000004072 C09CA03 - Valsartan Substances 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 241000237903 Hirudo Species 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000005001 Paeonia suffruticosa Species 0.000 description 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 241000237636 Pheretima Species 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000037114 Symptom Flare Up Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229960004530 benazepril Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 229910052956 cinnabar Inorganic materials 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 description 1
- 229960003009 clopidogrel Drugs 0.000 description 1
- 108010052008 colla corii asini Proteins 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000001747 discharging ear Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000010135 fructus aurantii immaturus Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000002816 gill Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000001515 vagal effect Effects 0.000 description 1
- SJSNUMAYCRRIOM-QFIPXVFZSA-N valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SJSNUMAYCRRIOM-QFIPXVFZSA-N 0.000 description 1
- 229960004699 valsartan Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
实验组 | 对照组 | |
例数 | 100 | 100 |
男性例数 | 60 | 58 |
女性例数 | 40 | 42 |
年龄(岁) | 32-81 | 32-81 |
临床治愈例数 | 95 | 52 |
有效例数 | 3 | 8 |
无效例数 | 2 | 40 |
总有效率 | 98% | 60% |
Claims (1)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510218869.8A CN104784476A (zh) | 2014-01-17 | 2014-01-17 | 一种治疗心律不齐的中药胶囊及制备方法 |
CN201510218894.6A CN104825795A (zh) | 2014-01-17 | 2014-01-17 | 治疗心律不齐的中药胶囊 |
CN201510218893.1A CN104825794A (zh) | 2014-01-17 | 2014-01-17 | 治疗心律不齐的中药及其制备方法 |
CN201410021576.6A CN103705733B (zh) | 2014-01-17 | 2014-01-17 | 一种治疗心律不齐的中药胶囊及其制备方法 |
CN201510219745.1A CN104825796A (zh) | 2014-01-17 | 2014-01-17 | 治疗心律不齐中药胶囊的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410021576.6A CN103705733B (zh) | 2014-01-17 | 2014-01-17 | 一种治疗心律不齐的中药胶囊及其制备方法 |
Related Child Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510219745.1A Division CN104825796A (zh) | 2014-01-17 | 2014-01-17 | 治疗心律不齐中药胶囊的制备方法 |
CN201510218893.1A Division CN104825794A (zh) | 2014-01-17 | 2014-01-17 | 治疗心律不齐的中药及其制备方法 |
CN201510218894.6A Division CN104825795A (zh) | 2014-01-17 | 2014-01-17 | 治疗心律不齐的中药胶囊 |
CN201510218869.8A Division CN104784476A (zh) | 2014-01-17 | 2014-01-17 | 一种治疗心律不齐的中药胶囊及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103705733A CN103705733A (zh) | 2014-04-09 |
CN103705733B true CN103705733B (zh) | 2015-09-30 |
Family
ID=50399320
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510218869.8A Pending CN104784476A (zh) | 2014-01-17 | 2014-01-17 | 一种治疗心律不齐的中药胶囊及制备方法 |
CN201510218894.6A Pending CN104825795A (zh) | 2014-01-17 | 2014-01-17 | 治疗心律不齐的中药胶囊 |
CN201410021576.6A Expired - Fee Related CN103705733B (zh) | 2014-01-17 | 2014-01-17 | 一种治疗心律不齐的中药胶囊及其制备方法 |
CN201510219745.1A Pending CN104825796A (zh) | 2014-01-17 | 2014-01-17 | 治疗心律不齐中药胶囊的制备方法 |
CN201510218893.1A Pending CN104825794A (zh) | 2014-01-17 | 2014-01-17 | 治疗心律不齐的中药及其制备方法 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510218869.8A Pending CN104784476A (zh) | 2014-01-17 | 2014-01-17 | 一种治疗心律不齐的中药胶囊及制备方法 |
CN201510218894.6A Pending CN104825795A (zh) | 2014-01-17 | 2014-01-17 | 治疗心律不齐的中药胶囊 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510219745.1A Pending CN104825796A (zh) | 2014-01-17 | 2014-01-17 | 治疗心律不齐中药胶囊的制备方法 |
CN201510218893.1A Pending CN104825794A (zh) | 2014-01-17 | 2014-01-17 | 治疗心律不齐的中药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (5) | CN104784476A (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105056074A (zh) * | 2015-08-28 | 2015-11-18 | 霍同颜 | 一种治疗心律不齐的方剂 |
CN105535635A (zh) * | 2016-01-20 | 2016-05-04 | 青岛云天生物技术有限公司 | 一种用于预防和治疗心律不齐的药物制剂及其制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02188529A (ja) * | 1989-01-13 | 1990-07-24 | Tsurataka Tashiro | 血管障害治療薬 |
CN1136444A (zh) * | 1995-05-22 | 1996-11-27 | 王希亚 | 心康宝 |
CN1148211C (zh) * | 2001-01-14 | 2004-05-05 | 刘红 | 用于治疗充血性心力衰竭的药物 |
CN1150018C (zh) * | 2001-01-16 | 2004-05-19 | 刘红 | 用于治疗快速心律失常的药物 |
CN1141965C (zh) * | 2001-03-20 | 2004-03-17 | 刘保健 | 一种治疗心脏病的药物 |
CN1634449A (zh) * | 2004-10-28 | 2005-07-06 | 陈泽涵 | 治疗心衰、心率不齐和心颤的药物及其制备方法 |
CN1899516A (zh) * | 2006-07-13 | 2007-01-24 | 潘首德 | 一种治疗冠心病心律失常所致心悸等症的药物及制备方法 |
CN100467055C (zh) * | 2006-10-17 | 2009-03-11 | 吴鹏 | 治疗心律失常、冠心病、心绞痛的外用药 |
CN101693099B (zh) * | 2009-11-06 | 2011-06-01 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗心动过速病证的中药组合物及其制备方法 |
CN101703698A (zh) * | 2009-11-18 | 2010-05-12 | 秦跃山 | 治疗心脏病的中药 |
CN101874891B (zh) * | 2010-04-26 | 2011-12-14 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗心悸的中药组合物及其制备方法 |
CN102258599B (zh) * | 2011-06-25 | 2013-03-13 | 臧鑫 | 一种治疗心血管病的中药药物 |
CN102363009B (zh) * | 2011-10-21 | 2012-09-05 | 北京同仁堂天然药物有限公司 | 一种具有滋阴助阳、培元固本功效的中药组合物 |
CN104107321A (zh) * | 2013-04-19 | 2014-10-22 | 辛舒畅 | 一种治疗冠心病的中药组合物 |
CN103405668B (zh) * | 2013-08-08 | 2015-02-11 | 武美英 | 一种治疗心律失常的药剂 |
-
2014
- 2014-01-17 CN CN201510218869.8A patent/CN104784476A/zh active Pending
- 2014-01-17 CN CN201510218894.6A patent/CN104825795A/zh active Pending
- 2014-01-17 CN CN201410021576.6A patent/CN103705733B/zh not_active Expired - Fee Related
- 2014-01-17 CN CN201510219745.1A patent/CN104825796A/zh active Pending
- 2014-01-17 CN CN201510218893.1A patent/CN104825794A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CN104825794A (zh) | 2015-08-12 |
CN103705733A (zh) | 2014-04-09 |
CN104784476A (zh) | 2015-07-22 |
CN104825795A (zh) | 2015-08-12 |
CN104825796A (zh) | 2015-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101642540B (zh) | 一种镇静安神的中成药 | |
CN104998017A (zh) | 一种排毒、滋阴补肾的中药及其制备方法 | |
CN103977358A (zh) | 一种降脂护肝的口服中药 | |
CN104740546A (zh) | 一种治疗胃癌的中药组合物 | |
CN104173773A (zh) | 偏头痛祛风活血制剂及制备方法 | |
CN104740437A (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
CN101518594A (zh) | 一种抗肿瘤及增强免疫力的中药制剂及其制备方法 | |
CN103705733B (zh) | 一种治疗心律不齐的中药胶囊及其制备方法 | |
CN106266999A (zh) | 一种治疗心神不安及心悸失眠的中药组合物及其制备方法 | |
CN105381424A (zh) | 一种用于人体脏腑排毒的中药剂及制备方法 | |
CN102293964B (zh) | 一种治疗胃溃疡的药物及其制备方法 | |
CN104623600A (zh) | 一种治疗末梢神经炎的中药及其制备方法 | |
CN104042981A (zh) | 一种治疗产后便秘的药剂及制备方法 | |
CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
CN104367700A (zh) | 一种治疗多发性神经炎的中药及其制备方法 | |
CN104043031A (zh) | 一种治疗抑郁症的中药 | |
CN105106438A (zh) | 一种治疗心律失常的中药组合物及其制备方法 | |
CN104857370A (zh) | 一种治疗乳腺癌症的中药组合物 | |
CN105106916A (zh) | 一种产后护理用中药 | |
CN103860990B (zh) | 冠心病活血通络散剂及制备方法 | |
CN102274358B (zh) | 一种治疗月经提前量多乳房胀痛血块多的中药 | |
CN104027528A (zh) | 一种治疗肾炎的中药丸 | |
CN104922595A (zh) | 一种用于带状疱疹的中药制剂及其制备方法 | |
CN104840827A (zh) | 一种治疗胃肠功能紊乱的健胃片剂及制法 | |
CN104587190A (zh) | 一种治疗心绞痛的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LIU JING Effective date: 20150817 Owner name: CHEN XIN Free format text: FORMER OWNER: LIU JING Effective date: 20150817 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150817 Address after: 250014 Shandong City, Ji'nan Province, the liberation of East Road, Lixia District, 34-1 modern Yi City building, unit 5, building 2, 1001 Applicant after: Chen Xin Applicant after: Liu Jing Address before: 271100, room 2, unit 4, building 196, 401 West Street, Laicheng street, Laicheng District, Shandong, Fengcheng, Laiwu Applicant before: Liu Jing |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 225400 Jiangsu Province, Taixing City Industrial Park Xiangrong Road No. 18 Patentee after: Chen Xin Patentee after: Liu Jing Address before: 250014 Shandong City, Ji'nan Province, the liberation of East Road, Lixia District, 34-1 modern Yi City building, unit 5, building 2, 1001 Patentee before: Chen Xin Patentee before: Liu Jing |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150930 Termination date: 20160117 |
|
EXPY | Termination of patent right or utility model |